178 related articles for article (PubMed ID: 10798666)
1. Erythrocyte sodium-lithium countertransport and proliferative diabetic retinopathy.
Lopes de Faria JM; Silveira LA; Morgano M; Pavin EJ; Lopes de Faria JB
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1482-5. PubMed ID: 10798666
[TBL] [Abstract][Full Text] [Related]
2. [Erythrocyte sodium-lithium countertransport in diabetic adolescents].
Guarena C; Boero R; Quarello F; Rolando B; Sacchetti C; Dianzani I; Maffei S; Cerutti F; Piccoli G
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1249-51. PubMed ID: 2124463
[TBL] [Abstract][Full Text] [Related]
3. [Erythrocyte sodium-lithium countertransport in diabetic children: 12 months development and relationship with familial hypertension].
Guarena C; Boero R; Quarello F; Cerruti F; Rolando B; Sacchetti C; Rosati C; Iadarola G; Piccoli G
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1205-7. PubMed ID: 1482260
[TBL] [Abstract][Full Text] [Related]
4. Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport.
Carr S; Mbanya JC; Thomas T; Keavey P; Taylor R; Alberti KG; Wilkinson R
N Engl J Med; 1990 Feb; 322(8):500-5. PubMed ID: 2300121
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes.
Vaccaro O; Cuomo V; Trevisan M; Cirillo M; Panarelli W; Laurenzi M; Mancini M; Riccardi G;
Int J Epidemiol; 2005 Oct; 34(5):1123-8. PubMed ID: 16087689
[TBL] [Abstract][Full Text] [Related]
6. Nonlinear relationship between erythrocyte sodium-lithium countertransport and blood pressure in man.
Petrov VV; Britov AN; Levitsky DO; Minchenko BI; Konstantinov EN; Svidersky VD; Novikov ID; Grishenkov EA; Lijnen PJ
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):661-6. PubMed ID: 7746028
[TBL] [Abstract][Full Text] [Related]
7. Abnormal thiol group modulation of sodium-lithium countertransport and membrane fluidity is associated with a disturbed relationship between serum triacylglycerols and membrane function in type II diabetes.
Senior PA; Thomas TH; Marshall SM
Clin Sci (Lond); 2000 Jun; 98(6):673-80. PubMed ID: 10814604
[TBL] [Abstract][Full Text] [Related]
8. Abnormal kinetics of erythrocyte sodium lithium countertransport in patients with diabetic nephropathy in Thailand.
Vareesangthip K; Panthongdee W; Shayakul C; Nitiyanant W; Ong-Aj-Yooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S48-53. PubMed ID: 17044454
[TBL] [Abstract][Full Text] [Related]
9. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
10. [Red-cell sodium-lithium countertransport in patients with IgA nephrology and renal hypertension].
Chen YD; Zheng FL; Wen LR
Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):214-7, 254. PubMed ID: 7922761
[TBL] [Abstract][Full Text] [Related]
11. The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study.
Klein R; Moss SE; Sinaiko AR; Zinman B; Gardiner R; Suissa S; Donnelly SM; Kramer MS; Goodyer P; Strand T; Mauer M
Ophthalmology; 2006 Dec; 113(12):2231-6. PubMed ID: 16996597
[TBL] [Abstract][Full Text] [Related]
12. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM.
Monciotti CG; Semplicini A; Morocutti A; Maioli M; Cipollina MR; Barzon I; Palaro C; Brocco E; Trevisan M; Fioretto P; Crepaldi G; Nosadini R
Diabetologia; 1997 Jun; 40(6):654-61. PubMed ID: 9222644
[TBL] [Abstract][Full Text] [Related]
13. Sodium-lithium countertransport activity as a determinant of deterioration of glomerular function in IgA nephropathy.
Kontessis PS; Friedman R; Tariq T; Moro F; Williams DG; Hartley RB; Viberti GC
Exp Nephrol; 1994; 2(3):176-81. PubMed ID: 7922270
[TBL] [Abstract][Full Text] [Related]
14. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy.
Mangili R; Bending JJ; Scott G; Li LK; Gupta A; Viberti G
N Engl J Med; 1988 Jan; 318(3):146-50. PubMed ID: 3336402
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein (A) levels in type 2 diabetic patients with diabetic retinopathy.
Ergün UG; Oztüzün S; Seydaoglu G
Med J Malaysia; 2004 Aug; 59(3):406-10. PubMed ID: 15727389
[TBL] [Abstract][Full Text] [Related]
16. [Disordered Na+/H+ metabolism in the erythrocytes of patients with insulin-dependent diabetes mellitus].
Balashova TS; Tomilova EN; Golega EN; Balabolkin MI; Kubatiev AA
Ter Arkh; 1996; 68(2):53-6. PubMed ID: 8771660
[TBL] [Abstract][Full Text] [Related]
17. G-protein beta3-subunit gene variant, blood pressure and erythrocyte sodium/lithium countertransport in essential hypertension.
Poch E; González-Núñez D; Compte M; De la Sierra A
Br J Biomed Sci; 2002; 59(2):101-4. PubMed ID: 12113397
[TBL] [Abstract][Full Text] [Related]
18. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
Chiarelli F; Catino M; Tumini S; de Martino M; Mezzetti A; Verrotti A; Vanelli M
Diabetes Care; 1999 Jul; 22(7):1158-64. PubMed ID: 10388982
[TBL] [Abstract][Full Text] [Related]
19. Transmembrane cationic fluxes in erythrocytes of diabetics and normal men.
Lijnen P; Fenyvesi A
Methods Find Exp Clin Pharmacol; 1994; 16(1):37-47. PubMed ID: 8164472
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
Gustavsson C; Agardh E; Bengtsson B; Agardh CD
J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]